Novartis “At An Inflection Point,” Announces $5B Buyback – ValueWalk Premium

Novartis “At An Inflection Point,” Announces $5B Buyback

In a move that reinforces its commitment to enhance returns to shareholders, Novartis AG (ADR) (NYSE:NVS) announced it will buy back shares worth $5B over the next two years, commencing immediately.

Novartis has reached an inflection point

"Novartis AG (ADR) (NYSE:NVS) has reached an inflection point, having fully integrated Alcon and reduced debt," said . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

The top investors are reading ValuewalkPremium.

Click here to learn why

0